BerandaRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Tutup sebelumnya
$7,26
Rentang hari
$6,78 - $7,08
Rentang tahun
$5,60 - $15,74
Kapitalisasi pasar
2,69Â M USD
Volume Rata-Rata
16,46Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 26,08Â jt | 147,62% |
Biaya operasional | 37,76Â jt | 29,31% |
Laba bersih | -95,84Â jt | -3,04% |
Margin laba bersih | -367,46 | 58,39% |
Penghasilan per saham | -0,34 | 20,93% |
EBITDA | -91,16Â jt | 0,89% |
Tarif pajak efektif | -0,17% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 427,65Â jt | 10,41% |
Total aset | 726,50Â jt | 15,17% |
Total liabilitas | 201,94Â jt | 4,71% |
Total ekuitas | 524,56 jt | — |
Saham yang beredar | 286,84 jt | — |
Harga terhadap nilai buku | 3,97 | — |
Tingkat pengembalian aset | -32,73% | — |
Tingkat pengembalian modal | -38,14% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -95,84Â jt | -3,04% |
Kas dari operasi | -59,22Â jt | 18,78% |
Kas dari investasi | -4,56Â jt | -1.214,70% |
Kas dari pembiayaan | 16,46Â jt | -69,38% |
Perubahan kas bersih | -46,92Â jt | -139,19% |
Arus kas bebas | -16,60Â jt | 70,89% |
Tentang
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering.
The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson. Wikipedia
Didirikan
2013
Kantor pusat
Situs
Karyawan
500
